Advanced search
Publication Cover
Leukemia & Lymphoma Volume 11, 1993 - Issue 1-2
Submit an article Journal homepage
28
Views
73
CrossRef citations to date
0
Altmetric
Original Article

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia Patients Treated with Fludarabine

Francesco Di Ramondo The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Rosario Giustolisi The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Emma Cacciola The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Susan O'Brien The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Hagop Kantarjian The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Lester B. Robertson The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
&
Michael J. Keating The Institute of Hematology, University of Catania, Italy; The Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
 show all
Pages 63-68 | Received 02 Jan 1993, Published online: 01 Jul 2009

Citations (73)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Tim R. De Back, Arnon P. Kater & Sanne H. Tonino. (2018) Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations. Expert Review of Hematology 11:8, pages 613-624.
Read now
Giovanni D'Arena$suffix/text()$suffix/text() & Nicola Cascavilla. (2007) Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & Lymphoma 48:6, pages 1072-1080.
Read now
Lev Shvidel, Mordechai Shtalrid, Osnat Bairey, Naomi Rahimi-Levene, Gilles Lugassy, Ofer Shpilberg, Aaron Polliack & Alain Berrebi. (2003) Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 44:11, pages 1947-1950.
Read now
Malcolm L. Brigden. (2001) Hematologic and oncologic emergencies. Postgraduate Medicine 109:3, pages 143-163.
Read now
Eric Van Den Neste, Andre Delannoy, Walter Feremans, Augustin Ferrant & Lucienne Michaux. (2001) Second Primary Tumors and Immune Phenomena After Fludarabine or 2-Chloro-2′-Deoxy adenosine Treatment. Leukemia & Lymphoma 40:5-6, pages 541-550.
Read now
Alexander S.D. Spiers. (2001) Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part I. Chronic Lymphocytic Leukemias. Hematology 6:5, pages 291-314.
Read now
Scott A. Tetreault & Alan Saven. (2000) Delayed Onset of Autoimmune Hemolytic Anemia Complicating Cladribine Therapy for Waldenström Macroglobulinemia. Leukemia & Lymphoma 37:1-2, pages 125-130.
Read now
Dimitar G. Efremov, Martin Ivanovski & Oscar R. Burrone. (1998) The Pathologic Significance of the Immunoglobulins Expressed by Chronic Lymphocytic Leukemia B-cells in the Development of Autoimmune Hemolytic Anemia. Leukemia & Lymphoma 28:3-4, pages 285-293.
Read now
R. C. Chasty, H. Myint, D. G. Oscier, J. A. Orchard, D. P. Bussutil, M. D. Hamon, A. G. Prentice & J. A. Copplestone. (1998) Autoimmune Haemolysis in Patients with B-CLL Treated with Chlorodeoxyadenosine (CDA). Leukemia & Lymphoma 29:3-4, pages 391-398.
Read now
Ciril Rozman & Emilio Montserrat. (1997) Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches. Hematology 2:1, pages 1-9.
Read now
E. Montserrat, J. L. López-Lorenzo, F. Manso, A. Martín, E. Prieto, J. Arias-Sampedro, M. N. Fernández, F. J. Oyarzábal, J. Odriozola, A. Alcalá, J. García-Conde, E. Conde, R. Guardia & F. Bosch. (1996) Fludarabine in Resistant or Relapsing B-Cell Chronic Lymphocytic Leukemia The Spanish Group Experience. Leukemia & Lymphoma 21:5-6, pages 467-472.
Read now
Michael Centola, Karen Lin, Christopher Sutton, James R. Berenson, Laurie A. Kunkel, Lee Rosen, Bevra H. Hahn & Randy R. Robinson. (1996) Production of anti-erythrocyte antibodies by leukemic and nonleukemic b cells in chronic lymphocytic leukemia patients. Leukemia & Lymphoma 20:5-6, pages 465-469.
Read now
S. B. Gjedde & M. M. Hansen. (1996) Salvage Therapy with Fludarabine in Patients with Progressive B-Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 21:3-4, pages 317-320.
Read now
Susan J. Wright & Michael J. Keating. (1995) Cyclosporine A in Chronic Lymphocytic Leukemia: Dual Anti-leukemic and Immunosuppressive Role?. Leukemia & Lymphoma 20:1-2, pages 131-136.
Read now
M. Montillo, A. Tedeschi & P. Leoni. (1994) Recurrence of Autoimmune Thrombocytopenia after Treatment with Fludarabine in a Patient with Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 15:1-2, pages 187-188.
Read now

Articles from other publishers (58)

Syed Saqib Ali, Ruchika Raj, Tejinder Kaur, Brenna Weadick, Debasis Nayak, Minnsung No, Jane Protos, Hannah Odom, Kajal Desai, Avinash K. Persaud, Joanne Wang & Rajgopal Govindarajan. (2022) Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective. Cancers 14:13, pages 3113.
Crossref
Candida Vitale, Chiara SalvettiValentina Griggio, Marika PorrazzoLuana SchiattoneGiulia ZamprognaAndrea Visentin, Francesco VassalloRamona CassinGian Matteo RigolinRoberta MurruLuca Laurenti, Paolo RivelaMonia Marchetti, Elsa PenneseMassimo Gentile, Elia Boccellato, Francesca PerutelliMaria Chiara MontalbanoLorenzo De Paoli, Gianluigi RedaLorella OrsucciLivio Trentin, Antonio CuneoAlessandra TedeschiLydia Scarfò, Gianluca Gaidano, Francesca Romana MauroRobin FoàMario Boccadoro & Marta Coscia. (2021) Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. Blood 137:25, pages 3507-3517.
Crossref
Natalia Kreiniz, Maya Garty‐Ofir, Jacob Bejar, Aaron Polliack & Tamar Tadmor. (2020) Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen. Hematological Oncology 39:1, pages 129-133.
Crossref
Vitale, Montalbano, Salvetti, Boccellato, Griggio, Boccadoro & Coscia. (2020) Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers 12:2, pages 282.
Crossref
G. GarrattyP.A. Arndt. (2014) Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology 30:2, pages 66-79.
Crossref
Giovanni D'Arena, Roberto Guariglia, Francesco La Rocca, Stefania Trino, Valentina Condelli, Laura De Martino, Vincenzo De Feo & Pellegrino Musto. (2013) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. Clinical and Developmental Immunology 2013, pages 1-8.
Crossref
Amy Hatfield Seung. (2010) Standard of care and novel treatments for chronic lymphocytic leukemia. American Journal of Health-System Pharmacy 67:21, pages 1813-1824.
Crossref
George Garratty. (2010) Immune hemolytic anemia associated with drug therapy. Blood Reviews 24:4-5, pages 143-150.
Crossref
Roberta Zanotti, Franzesco Frattini, Paolo Ghia, Carlo Visco, Alberto Zamò, Omar Perbellini, Stefania Stella, Monica Facco, Ilaria Giaretta, Marco Chilosi, Giovanni Pizzolo & Achille Ambrosetti. (2010) ZAP‐70 expression is associated with increased risk of autoimmune cytopenias in CLL patients. American Journal of Hematology 85:7, pages 494-498.
Crossref
P. Renaudier. (2008) Transfusion en hématologie. Transfusion Clinique et Biologique 15:5, pages 228-235.
Crossref
Barbara Eichhorst & Michael Hallek. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 121 139 .
Dennis Carney & John Seymour. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 231 260 .
Massimo Franchini, Giovanni Targher, Franco Manzato & Giuseppe Lippi. (2008) Acquired factor VIII inhibitors in oncohematology: A systematic review. Critical Reviews in Oncology/Hematology 66:3, pages 194-199.
Crossref
Gautam Borthakur, Susan O'Brien, William G. Wierda, Deborah A. Thomas, Jorge E. Cortes, Francis J. Giles, Hagop M. Kantarjian, Susan Lerner & Michael J. Keating. (2007) Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab ? incidence and predictors. British Journal of Haematology 136:6, pages 800-805.
Crossref
Dae Chul Jeong. (2007) Pharmacotherapy in Childhood Anemia. Journal of the Korean Medical Association 50:2, pages 170.
Crossref
G. GarrattyP.A. Arndt. (2007) An update on drug-induced immune hemolytic anemia. Immunohematology 23:3, pages 105-119.
Crossref
Tait D. Shanafelt & Neil E. Kay. (2007) Comprehensive Management of the CLL Patient: A Holistic Approach. Hematology 2007:1, pages 324-331.
Crossref
Karen W.L. Yee & Susan M. O'Brien. (2006) Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clinic Proceedings 81:8, pages 1105-1129.
Crossref
Giovanni D'Arena, Luca Laurenti, Silvana Capalbo, Alfonso Maria D'Arco, Rosaria De Filippi, Gianpaolo Marcacci, Nicola Di Renzo, Sergio Storti, Catello Califano, Maria Luigia Vigliotti, Michela Tarnani, Felicetto Ferrara & Antonio Pinto. (2006) Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. American Journal of Hematology 81:8, pages 598-602.
Crossref
Deniz L. Aslan, Bruce A. Peterson, Michaela Long-Tsai & Ted Eastlund. (2006) Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia. Transfusion 46:1, pages 90-94.
Crossref
Emili Montserrat & Elias Campo. 2006. The Lymphomas. The Lymphomas 406 414 .
Michael J. Keating, Susan O’Brien, Maher Albitar, Susan Lerner, William Plunkett, Francis Giles, Michael Andreeff, Jorge Cortes, Stefan Faderl, Deborah Thomas, Charles Koller, William Wierda, Michelle A. Detry, Alice Lynn & Hagop Kantarjian. (2005) Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 23:18, pages 4079-4088.
Crossref
Seung-Hwan MoonSeuk-Hee ChungDong-Sik JungChang-Jae LeeBong-Gun SeoSung-Hyun KimHyuk-Chan KwonJae-Seok KimHyo-Jin Kim. (2005) A Case of Autoimmune Hemolytic Anemia after Fludarabine Treatment in Waldenstrom Macroglobulinemia. The Korean Journal of Hematology 40:2, pages 116.
Crossref
Lawrence D. Petz & George Garratty. 2004. Immune Hemolytic Anemias. Immune Hemolytic Anemias 401 458 .
Lawrence D. Petz & George Garratty. 2004. Immune Hemolytic Anemias. Immune Hemolytic Anemias 261 317 .
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramU. Kaboth. 2004. Die Onkologie. Die Onkologie 763 779 .
Terry Hamblin. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 361 376 .
Tiffany Wells & Michael J Kovacs. (2016) Autoimmune Thrombocytopenia Due to Chronic Lymphocytic Leukemia Treated with Fludarabine. Annals of Pharmacotherapy 37:5, pages 671-674.
Crossref
N Gupta, S Kavuru, D Patel, D Janson, N Driscoll, S Ahmed & KR Rai. (2002) Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia 16:10, pages 2092-2095.
Crossref
Donald L. HelmanJrJr, John C. Byrd, Noel C. Ales & Andrew F. Shorr. (2002) Fludarabine-Related Pulmonary Toxicity. Chest 122:3, pages 785-790.
Crossref
T Robak & M Kasznicki. (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:6, pages 1015-1027.
Crossref
Karin Karlsson, Mats Strömberg, Jan Liliemark, André Delannoy, S. A. N. Johnson, Anja Porwit, Eva Kimby, Gerd Lärfars, Ilse Cristiansen, Göran Nilsson, Fredrik Celsing, Gunnel Sundström, Mikaela Luthman, Ulf Tidefelt, Jonas Wallvik & Gunnar Juliusson. (2002) Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients. British Journal of Haematology 116:3, pages 538-548.
Crossref
Stephane Cheze & Michel Leporrier. (2002) Chronic Lymphocytic Leukemia. American Journal of Cancer 1:2, pages 127-143.
Crossref
J. Cid, V. Beltran, L. Escoda, E. Elies & C. Martin-Vega. (2002) Autoanti-D in a patient after cladribine treatment for lymphoplasmocytic lymphoma. Immunohematology 18:1, pages 16-18.
Crossref
Terry J. Hamblin. (2001) Achieving Optimal Outcomes in Chronic Lymphocytic Leukaemia. Drugs 61:5, pages 593-611.
Crossref
G. Fleischhack, C. Hassan, N. Graf, G. Mann & U. Bode. 2001. Acute Leukemias VIII. Acute Leukemias VIII 544 554 .
C.W. Tiplady, P.J. Hamilton & M.J. Galloway. (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine. Clinical & Laboratory Haematology 22:3, pages 163-165.
Crossref
Francesca R. MauroRobert FoaRaffaella CerrettiDiana GiannarelliSerelina ColuzziFranco MandelliGabriella Girelli. (2000) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 95:9, pages 2786-2792.
Crossref
Robak, Błoński, Kasznicki, Konopka, Ceglarek, Dmoszyńska, Soroka‐Wojtaszko, Skotnicki, Nowak, Dwilewicz‐Trojaczek, Tomaszewska, Hellmann, Lewandowski, Kuliczkowski, Potoczek, Zdziarska, Hansz, Kroll, Komarnicki, Hołowiecki & Grieb. (2001) Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients. British Journal of Haematology 108:2, pages 357-368.
Crossref
Reich, Brinck, Letschert, Blaschke, Dames, Braess, Wörmann, Rünger & Neumann. (1999) Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. British Journal of Dermatology 141:4, pages 739-746.
Crossref
William G. Wierda & Thomas J. Kipps. (1999) Chronic lymphocytic leukemia. Current Opinion in Hematology 6:4, pages 253.
Crossref
Hesham M. Taha, Parths Narasihman, Latha Venkatesh, Margrete Cawley & Barry Kaplan. (1998) Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders. American Journal of Hematology 59:4, pages 316-316.
Crossref
Fleischhack, Hasan, Graf, Mann & Bode. (2001) IDA‐FLAG (idarubicin, fludarabine, cytarabine, G‐CSF), an effective remission‐induction therapy for poor‐prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. British Journal of Haematology 102:3, pages 647-655.
Crossref
Thomas P. LoughranJrJr. (2017) Anemia in Lymphoproliferative Disorders. Cancer Control 5:2_suppl, pages 51-53.
Crossref
Dan J. Vick, John C. Byrd, Connie L. Beal & Donald J. Chaffin. (2003) Mixed‐Type Autoimmune Hemolytic Anemia following Fludarabine Treatment in a Patient with Chronic Lymphocytic Leukemia/Small Cell Lymphoma. Vox Sanguinis 74:2, pages 122-126.
Crossref
Barbara Zimmer-Molsberger, Wolfgang Knauf & Eckhard Thiel. (1997) Mycophenolate mofetil for severe autoimmune haemolytic anemia. The Lancet 350:9083, pages 1003-1004.
Crossref
Giuseppe Longo, Giovanna Gandini, Leonardo Ferrara, Umberto Torelli & Giovanni Emilia. (2009) Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia. European Journal of Haematology 59:2, pages 124-125.
Crossref
T. Robak, M. Błasińska‐Morawiec, E. Krykowski, A. Hellmann & L. Konopka. (2009) Autoimmune haemolytic anaemia in patients with chronic lymphocytic eukaemia treated with 2‐chlorodeoxyadenosine (cladribine). European Journal of Haematology 58:2, pages 109-113.
Crossref
E. Montserrat, F. Bosch & C. Rozman. (1997) B-cell chronic lymphocytic leukemia: Recent progress in biology, diagnosis, and therapy. Annals of Oncology 8, pages S93-S101.
Crossref
S Crozat-Grosleron, D Reynaud, S Yeche, J.F. Rossi & A Dubois. (1996) Fludarabine et anémie hémolytique auto-immune grave: Une nouvelle observation. La Revue de Médecine Interne 17:8, pages 701-702.
Crossref
The French Cooperative Group on CLL, S Johnson, A.G Smith, H Löffler, E Ösby, G Juliusson, B Emmerich, P.J Wyld & W Hiddemann. (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The Lancet 347:9013, pages 1432-1438.
Crossref
S.A. Johnson. (1996) Purine analogues in the management of lymphoproliferative diseases. Clinical Oncology 8:5, pages 289-296.
Crossref
Marco Montillo, Alessandra Tedeschi, Costante Delfini, Attilio Olivieri, Francesca D'Adamo & Pietro Leoni. (2018) Effectiveness of Fludarabine in Advanced B-Cell Chronic Lymphocytic Leukemia. Tumori Journal 81:6, pages 419-423.
Crossref
H. Myint, J. A. Copplestone, J. Orchard, V. Craig, D. Curtis, A. G. Prentice, M. D. Hamon, D. G. Oscier & T. J. Hamblin. (2008) Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology 91:2, pages 341-344.
Crossref
A. Bazarbachi, H. Bachelez, L. Dehen, A. Delmer, R. Zittoun & L. Dubertret. (1995) Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Annals of Oncology 6:7, pages 730-731.
Crossref
Roger A. Fleischman & David Croy. (2006) Acute Onset of Severe Autoimmune Hemolytic Anemia After Treatment With 2‐Chlorodeoxyadenosine for Chronic Lymphocytic Leukemia. American Journal of Hematology 48:4, pages 293-293.
Crossref
J.C. Byrd, A.A. Hertler, R.B. Weiss, J. Freiman, S.L. Kweder & L.F. Diehl. (1995) Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Annals of Oncology 6:3, pages 300-301.
Crossref
E. Montserrat & C. Rozman. (1995) Chronic lymphocytic leukemia: Present status. Annals of Oncology 6:3, pages 219-235.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.